Saratoga (SAR) Q4 2026 Earnings Call Transcript

Saratoga Investment reported $8.5 million in adjusted NII and $101.1 million of net originations, with 82.1% first-lien exposure, 96.8% of credits in the top internal rating, and $210.8 million of available liquidity. However, NAV per share fell to $24.42, adjusted NII per share dropped to $0.53 due partly to a $1.7 million excise tax, and the company’s $0.75 quarterly dividend exceeded annual NII by $1.42 per share. Management flagged pressure from lower base rates, tighter spreads, and the CLO F note’s nonaccrual/write-down, but reiterated confidence in pipeline growth and selective deployment.

Analysis

SAR is still one of the cleaner public BDC expressions of a late-cycle private credit book, but the market is underpricing the gap between headline credit metrics and actual distributable earnings quality. The core issue is not credit loss today; it is that the dividend is being funded with a mix of yield compression, fee-like carry, and prior undistributed income, which makes NAV more sensitive to any slowdown in origination pace or further base-rate normalization. That creates a slow-burn setup: no imminent balance-sheet stress, but a relatively high probability of incremental dividend pressure over the next 2-3 quarters if asset growth does not outpace runoff.

The real second-order winner here is likely SAR's own funding flexibility, not the equity. The refinancing of legacy debt at materially higher coupons locks in a higher cost of capital just as new money spreads are tightening, which means the incremental spread on newly originated loans must compensate for both lower SOFR and higher liability costs. That math is manageable only if deal volume remains elevated; otherwise, earnings leverage turns negative fast because the company is carrying meaningful dry powder that earns nothing until deployed.

The CLO mark-down is the key contrarian tell. Investors may dismiss it as a niche issue, but structurally it signals that legacy structured-credit assets are moving into a maturation phase where refinancing optionality becomes the only route to value recovery. If execution on a CLO refi slips, the market will likely start capitalizing SAR on a lower-quality earnings stream and apply a discount to the dividend, even if nonaccruals stay low elsewhere in the book. In that sense, the stock can look fundamentally stable while the multiple compresses.

Consensus is likely too anchored on headline yield and too complacent on payout durability. The market is rewarding the visible 12%+ dividend but not fully discounting the fact that excess distributions have already been doing heavy lifting for NAV preservation. If management converts pipeline strength into sustained AUM growth, the stock can work; if not, the path of least resistance is a modest rerating lower as investors realize the current payout is less covered than it appears.

Key Decisions for Investors

• Long SAR only on pullbacks to a deeper discount to NAV; target 8-12% upside over 3-6 months if originations continue to outgrow repayments, but cut exposure if adjusted NII per share falls below ~$0.55 ex-excise on a run-rate basis.
• Pair trade: long quality BDCs with stronger dividend coverage and lower leverage vs short SAR over the next 1-2 quarters, betting the market eventually punishes weaker payout coverage despite superior reported ROE.
• Use a covered-call structure on SAR rather than outright long equity for income investors: the dividend supports carry, while upside is capped but downside is partially offset if NAV erosion or dividend skepticism re-emerges.
• Avoid adding into strength until the CLO refinancing path is clearer; the embedded option value is real, but failure to refinance would likely be a catalyst for another de-rating within 6-12 months.
• If seeking rate-sensitive credit exposure, prefer senior-loan managers with cleaner fee coverage over SAR; SAR's equity behaves more like a leveraged spread-reset story than a pure yield vehicle.